Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 1717-1728 of 1784 results.
"Administering intravenous chemotherapy in an ICU setting remains challenging, and the experience to establish an indication for systemic chemotherapy is still challenging" Karagiannis et al (2025).
"This study found that many patients are not aware that anaesthetists are medically qualified. Exposure to anaesthetists on the day of surgery did not improve patients' knowledge of the roles of anaesthetists or their knowledge of anaesthesia itself" Baker and Varadan (2024).
"The pharmacy intravenous admixture service (PIVAS) center is a professional technical service department in hospitals, where the majority of inpatient-administered infusion solutions are prepared" Wang et al (2025).
"This proprietary and novel machine learning algorithm can accurately and reliably predict PIVC failure 1 day prior to clinically evident failure" Bahl et al (2025).
"This study identified six risk factors associated with central venous CRI in MHD patients. This predictive model demonstrates good prognostic performance and can be used by clinicians to screen for high-risk patients with central venous CRI, thereby enabling the early implementation of risk management strategies" Guo et al (2025).
"A risk prediction model has been developed to identify infants at a greater risk of an adverse event associated with umbilical arterial catheters. The model needs to be externally validated before it can be implemented into clinical practice" Gibson et al (2025).
"To report the feasibility of a fluid management practice bundle and describe the pre- vs. post-implementation prevalence and odds of cumulative fluid balance greater than 10% in critically ill pediatric patients with respiratory failure" Foglia et al (2025).
"In a prospective study we found that in hospitalized patients with diabetes the use of mid line venous catheter (MVC) resulted in a significantly lower rate of vascular complications than short cannulas" Rivas et al (2025).
"The aim of this study is to evaluate the incidences of colonization and central line-associated bloodstream infections (CLABSI) in short-term CVCs in the elective surgery setting, as well as to analyze the related risk factors" Becerra-Bolaños et al (2025).
"The novel lateral in-plane short-axis approach for IJV cannulation is a non-inferior alternative with a lower incidence of posterior vessel wall puncture compared to the conventional approach" Kalina et al (2025).
"An expert panel of clinicians was convened by Outset Medical, a manufacturer of hemodialysis systems, to review the literature and generate consensus recommendations regarding the use of CVCs for HHD. Consistent with the most recent Kidney Disease Outcomes vascular access guidelines, the end-stage kidney disease life plan should be created via shared decision making for modality choices, with the corresponding dialysis access individualized for the patient, and for whom a CVC may represent the most appropriate vascular access to provide HHD" Aragon et al (2024).
"To verify the effects of instructional therapeutic play on the behavior of children during the first attempt at peripheral intravenous catheterization" Santos et al (2025).
